A to Z
Data &
Forms &
News &
Licensing &
Rules &
Public Health
Submitting Specimens for Zika Virus Testing

The OSPHL currently tests for Zika virus using the Centers for Disease Control and Prevention (CDC) methods under FDA Emergency Use Authorization (EUA) and verified by acceptable CLIA standards. Certain specimens may be forwarded to the CDC for testing based on the CDC's Zika virus testing algorithms.

All testing for Zika virus must be pre-approved by local or state public health officials prior to specimen submission.

Specimen Collection, Handling, and Transport Information

If testing is approved, collect specimen(s) consistent with the instructions on the OSPHL Lab Test Menu.

  • If specimen collection is up to 13 days (<2 weeks) from symptom onset or possible Zika virus exposure, follow the instructions for Trioplex PCR.
  • If specimen collection is between 14 days (2 weeks) and 12 weeks after symptom onset or possible Zika virus exposure, follow the instructions for Zika IgM

If you are instructed by County or State Public Health officials to collect tissue specimens, please follow the CDC Instructions for Collecting Fetal Tissue Specimens for Zika Virus Testing closely.

Do not ship specimens directly to the CDC; ship to the OSPHL with the forms listed below.

Specimens may be forwarded to the CDC by the OSPHL for subsequent or confirmatory testing per CDC testing algorithms.

Required Forms

Please submit the following forms with the specimen(s):

(If you need a copy of this form, please check with your facility's laboratory or contact the OSPHL Virology/Immunology Section at 503-693-4100.)


Additional Information